Why the study?
Can a self-starting Cumulative Sum control chart accurately assess individualized blood pressure and heart rate responses to a change in antihypertensive medication?
Can a self-starting Cumulative Sum control chart accurately assess individualized blood pressure and heart rate responses to a change in antihypertensive medication?
Individualized statistical process control charts (cusum) can effectively monitor and interpret a patient's physiological response to changes in antihypertensive therapy.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for cusum monitoring of individual antihypertensive responses; prospective trials needed before clinical adoption.
A self-interpreted control chart, on an individualized basis, assesses the effect of a switch from beta-blockers to an angiotensin-converting enzyme (ACE)-inhibitor in a patient with occasional blood pressure (BP) excess. In dense and long data series, the BP and heart rate (HR) of this patient respond to the change in treatment by the test criterion of a self-starting Cumulative Sum (cusum), which reaches values outside a decision interval with a lowering of BP and an increase in HR and vice versa, at least for BP, after treatment cessation. Thereafter, minimal sampling requirements are sought in the same data by applying the same control chart approach to decimated data. Skeleton sampling schemes in a system of chronobiologic self-analysis and interpretation of manually recorded data obtained at strategically placed times (established on the basis of data decimations) could complement control charts that are used on a home computer or preferably would be built into the output of ambulatory monitors used at the outset as a minimum and routinely as an optimum.
No takes yet. Share an insight, caveat, or question.
Cornélissen et al. (1997) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: